Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RPG LIFE SCIENCES 2022-23 Annual Report Analysis
Mon, 17 Jul

RPG LIFE SCIENCES has announced its results for the year ended March 2023. Let us have a look at the detailed performance review of the company during FY22-23.

RPG LIFE SCIENCES Income Statement Analysis

  • Operating income during the year rose 16.5% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 18.8% YoY during the fiscal. Operating profit margins witnessed a fall and down at 20.2% in FY23 as against 19.8% in FY22.
  • Depreciation charges decreased by 1.1% and finance costs decreased by 18.4% YoY, respectively.
  • Other income grew by 55.8% YoY.
  • Net profit for the year grew by 31.4% YoY.
  • Net profit margins during the year grew from 11.7% in FY22 to 13.2% in FY23.

RPG LIFE SCIENCES Income Statement 2022-23

No. of Mths Year Ending 12 Mar-22* 12 Mar-23* % Change
Net Sales Rs m 4,402 5,128 16.5%
Other income Rs m 31 48 55.8%
Total Revenues Rs m 4,432 5,176 16.8%
Gross profit Rs m 872 1,035 18.8%
Depreciation Rs m 157 155 -1.1%
Interest Rs m 14 12 -18.4%
Profit before tax Rs m 732 917 25.3%
Tax Rs m 217 240 10.8%
Profit after tax Rs m 515 676 31.4%
Gross profit margin % 19.8 20.2
Effective tax rate % 29.6 26.2
Net profit margin % 11.7 13.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...

RPG LIFE SCIENCES Balance Sheet Analysis

  • The company's current liabilities during FY23 stood at Rs 1 billion as compared to Rs 801 million in FY22, thereby witnessing an increase of 28.3%.
  • Current assets rose 28% and stood at Rs 3 billion, while fixed assets rose 13% and stood at Rs 2 billion in FY23.
  • Overall, the total assets and liabilities for FY23 stood at Rs 4 billion as against Rs 3 billion during FY22, thereby witnessing a growth of 22%.

RPG LIFE SCIENCES Balance Sheet as on March 2023

No. of Mths Year Ending 12 Mar-22* 12 Mar-23* % Change
Networth Rs m 2,558 3,076 20.3
 
Current Liabilities Rs m 801 1,028 28.3
Long-term Debt Rs m 3 0 -100.0
Total Liabilities Rs m 3,446 4,194 21.7
 
Current assets Rs m 2,069 2,641 27.6
Fixed Assets Rs m 1,377 1,553 12.8
Total Assets Rs m 3,446 4,194 21.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



RPG LIFE SCIENCES Cash Flow Statement Analysis

  • RPG LIFE SCIENCES's cash flow from operating activities (CFO) during FY23 stood at Rs 908 million, an improvement of 40.3% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY23 stood at Rs -1 billion, an improvement of 205.3% on a YoY basis.
  • Cash flow from financial activities (CFF) during FY23 stood at Rs -171 million on a YoY basis.
  • Overall, net cash flows for the company during FY23 stood at Rs -321 million from the Rs 166 million net cash flows seen during FY22.

RPG LIFE SCIENCES Cash Flow Statement 2022-23

Particulars No. of months 12 12 % Change
Year Ending Mar-22 Mar-23
Cash Flow from Operating Activities Rs m 648 908 40.3%
Cash Flow from Investing Activities Rs m -347 -1,058 -
Cash Flow from Financing Activities Rs m -135 -171 -
Net Cash Flow Rs m 166 -321 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for RPG LIFE SCIENCES

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 40.9, an improvement from the EPS of Rs 31.1 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 976.4, stands at 23.9 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 5.2 times, while the price to sales ratio stands at 3.1 times.
  • The company's price to cash flow (P/CF) ratio stood at 14.6 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-22* 12 Mar-23*
Sales per share (Unadj.) Rs 266.1 310.0
TTM Earnings per share Rs 31.1 40.9
Diluted earnings per share Rs 31.1 40.9
Price to Cash Flow x 13.8 14.6
TTM P/E ratio x 18.0 23.9
Price / Book Value ratio x 3.6 3.9
Market Cap Rs m 9,317 12,109
Dividends per share (Unadj.) Rs 9.6 12.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for RPG LIFE SCIENCES

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 2.6x during FY23, from 2.6x during FY22. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 80.7x during FY23, from 52.9x during FY22. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 22.0% during FY23, from 20.1% during FY23. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 30.2% during FY23, from 29.1% during FY22. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 16.4% during FY23, from 15.3% during FY22. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-22* 12 Mar-23*
Current ratio x 2.6 2.6
Debtors’ Days Days 274 266
Interest coverage x 52.9 80.7
Debt to equity ratio x 0.0 0.0
Return on assets % 15.3 16.4
Return on equity % 20.1 22.0
Return on capital employed % 29.1 30.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how RPG LIFE SCIENCES has performed over the last 5 years, please visit here.

RPG LIFE SCIENCES Share Price Performance

Over the last one year, RPG LIFE SCIENCES share price has moved up from Rs 562.6 to Rs 976.4, registering a gain of Rs 413.8 or around 73.6%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 26,443.1 (up 0.8%). Over the last one year it has moved up from 22,591.9 to 26,443.1, a gain of 3,851 points (up 17.0%).

Overall, the S&P BSE SENSEX is up 24.4% over the year.

(To know more, check out historical annual results for RPG LIFE SCIENCES and quarterly results for RPG LIFE SCIENCES)

Annual Report FAQs

What is the current share price of RPG LIFE SCIENCES?

RPG LIFE SCIENCES currently trades at Rs 1,567.5 per share. You can check out the latest share price performance of RPG LIFE SCIENCES here...

What was the revenue of RPG LIFE SCIENCES in FY23? How does it compare to earlier years?

The revenues of RPG LIFE SCIENCES stood at Rs 5,176 m in FY23, which was up 16.8% compared to Rs 4,432 m reported in FY22.

RPG LIFE SCIENCES' revenue has grown from Rs 3,310 m in FY19 to Rs 5,176 m in FY23.

Over the past 5 years, the revenue of RPG LIFE SCIENCES has grown at a CAGR of 11.8%.

What was the net profit of RPG LIFE SCIENCES in FY23? How does it compare to earlier years?

The net profit of RPG LIFE SCIENCES stood at Rs 676 m in FY23, which was up 31.4% compared to Rs 515 m reported in FY22.

This compares to a net profit of Rs 400 m in FY21 and a net profit of Rs 290 m in FY20.

Over the past 5 years, RPG LIFE SCIENCES net profit has grown at a CAGR of 58.2%.

What does the cash flow statement of RPG LIFE SCIENCES reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of RPG LIFE SCIENCES reveals:

  • Cash flow from operations increased in FY23 and stood at Rs 908 m as compared to Rs 648 m in FY22.
  • Cash flow from investments decreased in FY23 and stood at Rs -1,058 m as compared to Rs -347 m in FY22.
  • Cash flow from financial activity decreased in FY23 and stood at Rs -171 m as compared to Rs -135 m in FY22.

Here's the cash flow statement of RPG LIFE SCIENCES for the past 5 years.

(Rs m)FY19FY20FY21FY22FY23
From Operations458502583648908
From Investments-190-107-80-347-1,058
From Financial Activity-265-393-105-135-171
Net Cashflow32398166-321

What does the Key Ratio analysis of RPG LIFE SCIENCES reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of RPG LIFE SCIENCES reveals:

  • Operating profit margins witnessed a fall and down at 20.2% in FY23 as against 19.8% in FY22.
  • Net profit margins grew from 11.7% in FY22 to 13.2% in FY23.
  • Debt to Equity ratio for FY23 stood at 0.0 as compared to 0.0 in FY22.

Here's the ratio/financial analysis of RPG LIFE SCIENCES for the past 5 years.

 FY19FY20FY21FY22FY23
Operating Profit Margin (%)10.414.518.219.820.2
Net Profit Margin (%)3.37.710.311.713.2
Debt to Equity Ratio (x)0.00.00.00.00.0

 

Equitymaster requests your view! Post a comment on "RPG LIFE SCIENCES 2022-23 Annual Report Analysis". Click here!